Harvard scientists have created a new antibiotic that kills superbugs

Harvard scientists' new synthetic antibiotic, cresomycin, combats drug-resistant bacteria (killing over 1 million yearly) is a major leap forward as existing natural antibiotics are losing effectiveness due to resistance.

Cresomycin's advantage lies in its synthetic nature. Unlike traditional antibiotics that target ribosomes (essential for bacterial growth) and can be deactivated by bacterial defenses, cresomycin is specifically designed to overcome these defenses.

Antimicrobial resistance (AMR) is a critical public health threat. If left unchecked, AMR-related deaths could reach 10 million annually by 2050.

Researchers are exploring new avenues in the fight against superbugs. Scientists at MIT have utilized artificial intelligence (AI) to identify the first new antibiotic candidates in decades

The World Economic Forum's Global Future Council on the Future of Tackling Antimicrobial Resistance is an initiative dedicated to finding innovative approaches to combat AMR.